Luca Antonioli Selected Research

2,4-dinitrobenzene

8/2022	Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis.
1/2020	The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Antonioli Research Topics

Disease

42	Inflammation (Inflammations) 12/2023 - 02/2006
15	Colitis 02/2023 - 02/2006
15	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 04/2008
13	Obesity 03/2023 - 11/2017
11	Neoplasms (Cancer) 01/2023 - 12/2013
6	Pain (Aches) 01/2020 - 01/2006
5	Sepsis (Septicemia) 09/2023 - 06/2012
5	Body Weight (Weight, Body) 03/2023 - 08/2007
5	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 01/2019
5	Crohn Disease (Crohn's Disease) 05/2020 - 04/2017
4	Ischemia 01/2023 - 12/2008
4	Ulcerative Colitis 02/2021 - 04/2017
4	Wounds and Injuries (Trauma) 12/2017 - 07/2005
3	Hypertension (High Blood Pressure) 01/2023 - 01/2021
3	Atherosclerosis 01/2023 - 11/2020
3	Multiple Sclerosis 11/2020 - 01/2019
3	Rheumatoid Arthritis 11/2020 - 06/2012
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2015
3	Ulcer 07/2012 - 03/2009
3	Stomach Ulcer (Gastric Ulcer) 07/2012 - 03/2009
2	Necrosis 12/2023 - 11/2023
2	Fibrosis (Cirrhosis) 02/2023 - 02/2015
2	Myocardial Infarction 01/2023 - 01/2021
2	Heart Failure 01/2023 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2021
2	Morbid Obesity 08/2022 - 01/2020
2	Weight Loss (Weight Reduction) 08/2022 - 01/2020
2	Insulin Resistance 08/2022 - 01/2020
2	Infections 05/2022 - 01/2019
2	Cognitive Dysfunction 12/2021 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2019
2	Neuroinflammatory Diseases 06/2019 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 06/2019 - 02/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 01/2019
2	Hemorrhage 02/2016 - 06/2009
2	Peptic Ulcer (Peptic Ulcers) 02/2009 - 01/2008

Drug/Important Bio-Agent (IBA)

24	Adenosine (Adenocard)FDA LinkGeneric 09/2023 - 02/2006
13	2,4-dinitrobenzenesulfonic acidIBA 02/2023 - 02/2006
10	2,4-dinitrofluorobenzene sulfonic acidIBA 02/2023 - 06/2006
10	InflammasomesIBA 08/2022 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2016
8	CytokinesIBA 05/2020 - 08/2007
8	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 07/2005
7	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2022 - 04/2008
6	Adenosine Triphosphate (ATP)IBA 09/2023 - 12/2008
6	NucleotidesIBA 01/2021 - 01/2017
5	Purinergic Receptors (Receptors, Purine)IBA 01/2023 - 04/2008
5	Biomarkers (Surrogate Marker)IBA 10/2022 - 02/2016
5	Dexamethasone (Maxidex)FDA LinkGeneric 06/2021 - 08/2007
5	Leucine (L-Leucine)FDA Link 01/2021 - 01/2017
5	EnzymesIBA 01/2021 - 04/2008
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2023 - 01/2006
4	vedolizumabIBA 10/2022 - 01/2020
4	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 04/2015
4	Monoclonal AntibodiesIBA 05/2020 - 01/2010
3	Malondialdehyde (Propanedial)IBA 12/2023 - 03/2009
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2023 - 01/2020
3	Diclofenac (SR 38)FDA LinkGeneric 12/2023 - 07/2005
3	Oncostatin MIBA 10/2022 - 01/2020
3	Infliximab (Remicade)FDA Link 10/2022 - 01/2020
3	NucleosidesIBA 01/2021 - 03/2016
3	CollagenIBA 01/2020 - 01/2015
3	Cholinergic Agents (Cholinergics)IBA 02/2016 - 02/2006
3	Protein Isoforms (Isoforms)IBA 07/2012 - 01/2006
3	Adenosine DeaminaseIBA 06/2012 - 08/2007
2	Peroxidase (Myeloperoxidase)IBA 12/2023 - 02/2016
2	OccludinIBA 12/2023 - 08/2022
2	Butyrates (Butyrate)IBA 12/2023 - 01/2023
2	LigandsIBA 01/2023 - 01/2018
2	Sulfonic AcidsIBA 08/2022 - 01/2020
2	2,4-dinitrobenzeneIBA 08/2022 - 01/2020
2	Purinergic P2X4 ReceptorsIBA 08/2022 - 01/2019
2	Caspase 1 (ICE Protease)IBA 08/2022 - 01/2018
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2022 - 02/2006
2	CholesterolIBA 10/2021 - 03/2014
2	LipidsIBA 01/2021 - 02/2016
2	Immunomodulating AgentsIBA 11/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 05/2020 - 11/2010
2	InterleukinsIBA 01/2020 - 01/2019
2	FlavonoidsIBA 12/2018 - 01/2018
2	AntioxidantsIBA 12/2018 - 01/2018
2	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 09/2015 - 01/2014
2	Indomethacin (Indometacin)FDA LinkGeneric 07/2012 - 03/2009
2	SC 560IBA 07/2012 - 06/2006
2	Caspase 3 (Caspase-3)IBA 07/2012 - 03/2009
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2012 - 03/2009
2	Acetic Acid (Vinegar)FDA LinkGeneric 07/2012 - 03/2009
2	VaccinesIBA 01/2012 - 04/2011
2	AcidsIBA 01/2011 - 03/2009
2	Proton Pump InhibitorsIBA 01/2011 - 03/2009
2	pyrazoleIBA 11/2010 - 08/2007
2	pyrimidineIBA 11/2010 - 08/2007
2	9-(2-hydroxy-3-nonyl)adenine (EHNA)IBA 11/2010 - 08/2007
2	Paroxetine (Paxil)FDA LinkGeneric 07/2010 - 06/2009
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2006 - 03/2005

Therapy/Procedure

7	Therapeutics 01/2023 - 02/2016
3	Immunotherapy 01/2023 - 02/2016
2	Bariatric Surgery 08/2022 - 01/2020
2	Biological Therapy 12/2019 - 02/2016
2	Drug Therapy (Chemotherapy) 11/2017 - 04/2008